Ubrogepant (Ubrelvy, Allergan) was approved for the treatment of acute migraines with or without aura in adults after showing a significantly greater reduction in headache pain compared with placebo.
Michelle Putney, PharmD Candidate
Advertisement
Articles by Michelle Putney, PharmD Candidate
Advertisement
Latest Updated Articles
Ubrelvy: Treatment for Acute Migraines With or Without Aura in AdultsPublished: October 22nd 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Is Berberine Nature’s GLP-1?
2
Experts Highlight Key Sessions and Emerging Topics from The Menopause Society 2025 Annual Meeting
3
Glucodensity Analysis Enhances CGM Accuracy for Detecting Cystic Fibrosis–Related Diabetes
4
Because Ned Said: America’s Growing Pharmacy Deserts Are Leaving Patients High and Dry
5
